Zamarin, Dmitriy
- Icahn School of Medicine at Mount Sinai · Obstetrics & Gynecology (NIH department code)
- Icahn School of Medicine at Mount Sinai · Internal Medicine (NIH department code)
- Memorial Sloan Kettering Cancer Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #7,511
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2023 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Obstetrics & Gynecology
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$1.3M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#7,511
By linked amount among FY2023 PIs
Earliest Year Loaded
2023
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2023): $1.3M in linked award amounts across 4 award records · Award-linked rank #7511.
FY2023 award records by amount
NIH award records listing Zamarin, Dmitriy as a PI. Multi-PI records show the full award amount for context.
- 7R01CA276087-02R01Contact PIImmunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiationIcahn School of Medicine at Mount Sinai · Obstetrics & Gynecology (NIH department code)$595.4Kaward amount
- 7R01CA269382-02R01Contact PIPOTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATIONIcahn School of Medicine at Mount Sinai · Internal Medicine (NIH department code)$565.1Kaward amount
- 1R01CA269382-01A1R01Contact PIPOTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION$79.3Kaward amount
- 1R01CA276087-01A1R01Contact PIImmunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation$23.2Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Zamarin, Dmitriy as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2023First NIH AwardIcahn School of Medicine at Mount Sinai
- 2023$500K Cumulative Funding
- 2023$1M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #7511
- 2023Multi-Institutional ResearchAwards at 2 institutions